首页> 美国卫生研究院文献>Journal of Virology >Evolution of Bacteriophage in Continuous Culture: a Model System To Test Antiviral Gene Therapies for the Emergence of Phage Escape Mutants
【2h】

Evolution of Bacteriophage in Continuous Culture: a Model System To Test Antiviral Gene Therapies for the Emergence of Phage Escape Mutants

机译:噬菌体在连续培养中的演变:模型系统测试噬菌体逃生突变体的抗病毒基因疗法的出现。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The emergence of viral escape mutants is usually a highly undesirable phenomenon. This phenomenon is frequently observed in antiviral drug applications for the treatment of viral infections and can undermine long-term therapeutic success. Here, we propose a strategy for evaluating a given antiviral approach in terms of its potential to provoke the appearance of resistant virus mutants. By use of Qβ RNA phage as a model system, the effect of an antiviral gene therapy, i.e., a virus-specific repressor protein expressed by a recombinant Escherichia coli host, was studied over the course of more than 100 generations. In 13 experiments carried out in parallel, 12 phage populations became resistant and 1 became extinct. Sequence analysis revealed that only two distinct phage mutants emerged in the 12 surviving phage populations. For both escape mutants, sequence variations located in the repressor binding site of the viral genomic RNA, which decrease affinity for the repressor protein, conferred resistance to translational repression. The results clearly suggest the feasibility of the proposed strategy for the evaluation of antiviral approaches in terms of their potential to allow resistant mutants to appear. In addition, the strategy proved to be a valuable tool for observing virus-specific molecular targets under the impact of antiviral drugs.
机译:病毒逃逸突变体的出现通常是非常不希望的现象。这种现象在用于治疗病毒感染的抗病毒药物应用中经常观察到,并且可能破坏长期的治疗成功。在这里,我们提出了一种评估给定抗病毒方法的策略,该方法可能会引起耐药性病毒突变体的出现。通过使用QβRNA噬菌体作为模型系统,研究了抗病毒基因治疗的效果,即重组大肠杆菌宿主表达的病毒特异性阻遏蛋白的作用已超过100代。在平行进行的13个实验中,有12个噬菌体种群具有耐药性,有1个物种已灭绝。序列分析表明,在12个存活的噬菌体群体中仅出现了两个不同的噬菌体突变体。对于两个逃避突变体,位于病毒基因组RNA阻遏物结合位点的序列变异降低了对阻遏蛋白的亲和力,赋予了对翻译阻抑的抗性。结果清楚地表明,就其允许耐药突变体出现的潜力而言,所提出策略用于评估抗病毒方法的可行性。此外,该策略被证明是在抗病毒药物的影响下观察病毒特异性分子靶标的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号